Corcept Therapeutics Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · Redwood City, CA
CORT chart
What traders are saying about $CORT
Latest postsCorcept Therapeutics Inc news
- BlackRock updates its Corcept Therapeutics (CORT) stake, reporting sole voting power over 9.29M shares.
Stock Titan ·
- Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
Yahoo Finance ·
- Corcept Therapeutics Incorporated (CORT) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Piper Sandler Keeps Their Buy Rating on Corcept Therapeutics (CORT)
The Globe and Mail ·
- Corcept Therapeutics (CORT) Reports Positive BELLA Data, Is It Still 38% Undervalued?
Simply Wall Street ·
- CCORF Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Maintains Target Price $161
Moomoo ·
- Corcept Therapeutics Incorporated (CORT) stock price, news, quote and history
Yahoo Finance UK ·
- What Corcept Therapeutics Stock Positive Trial Results Mean For Shareholders
Yahoo Finance ·
- Corcept Therapeutics (CORT) Jumps 5.9% to $90.92
AlphaStreet ·
- Why Is Corcept Therapeutics Stock Trading Higher Today? - Corcept Therapeutics (NASDAQ:CORT)
Benzinga ·
- Why is Corcept Therapeutics stock rallying today? By Investing.com
Investing.com Nigeria ·
- Corcept Therapeutics (NASDAQ:CORT) Reports Positive Phase 2 BELLA Ovarian Cancer Data
Kalkine ·
Corcept Therapeutics Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $761.4M | $675.0M | $482.4M | $401.9M |
| Net income | $99.7M | $141.2M | $106.1M | $101.4M |
| Diluted EPS | $0.82 | $1.23 | $0.94 | $0.87 |
| Total assets (year end) | $836.7M | $840.6M | $621.5M | $583.4M |
| Cash and equivalents (year end) | $120.5M | $127.7M | $135.6M | $66.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Corcept Therapeutics Inc
- Ticker
- CORT (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Redwood City, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1088856
Frequently asked questions
What exchange is Corcept Therapeutics Inc listed on?
Corcept Therapeutics Inc trades on the Nasdaq under the ticker symbol CORT.
What industry is Corcept Therapeutics Inc in?
Corcept Therapeutics Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Corcept Therapeutics Inc headquartered?
Corcept Therapeutics Inc's business address on file with the SEC is in Redwood City, CA.
When does Corcept Therapeutics Inc's fiscal year end?
Corcept Therapeutics Inc's fiscal year ends on December 31.
How much revenue did Corcept Therapeutics Inc report?
Corcept Therapeutics Inc reported $761.4M in revenue for calendar year 2025, according to its SEC filings.